Pharmafile Logo
Pharmafocus logo
Advanced Search

Lexapro

Showing 5 posts of 5 posts found.

Lundbeck cuts more jobs in Europe

June 24, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Lexapro, Lundbeck, cuts

Lundbeck is to cut yet more jobs in Europe as the Danish pharma firm restructures its operations to focus on …

News

Promise for Lundbeck and Takeda’s depression drug

May 20, 2013
Research and Development, Sales and Marketing Lexapro, Lundbeck, Takeda, cymbalta, depression, lilly

Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …

News

Lundbeck moves ahead in Q1

May 3, 2013
Sales and Marketing Lexapro, Lundbeck, Otsuka, Q1

Lundbeck’s sales and profit increase in the first three months of 2013 was due largely to one-off payments it received, …

News

Lexapro US loss hits Lundbeck

February 7, 2013
Sales and Marketing Danish, Lexapro, Lundbeck

The loss of US patent protection on antidepressant Lexapro has put a significant dent in Lundbeck’s financial performance for 2012. …

News

Lundbeck issues Lexapro patent warning

November 3, 2010
Sales and Marketing Azilect, Cipralex, Forest Laboratories, Lexapro, Lundbeck, Xenazine

Neurological disorder specialist Lundbeck has posted a modest growth in revenue for the third quarter, but warned the looming patent …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025